A

Anthony Lucci

The University of Texas MD Anderson Cancer Center

ORCID: 0000-0003-4039-174X

565 papers and 21.2k citations.

PubIndex Score90Top 10% · seniorHow it's scored

565Publications

21.2kTotal Citations

First publication: 1997First senior author: 2001

Top publicationsby citations

Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis

François‐Clément Bidard, Paul Cottu, Andreas D. Hartkopf et al.|JNCI Journal of the National Cancer Institute|2018

Cited by 282

Important Role of FTO in the Survival of Rare Panresistant Triple-Negative Inflammatory Breast Cancer Cells Facing a Severe Metabolic Challenge

Balraj Singh, Anthony Lucci|PLoS ONE|2016

Cited by 137

Inhibition of resistant triple-negative breast cancer cells with low-dose 6-mercaptopurine and 5-azacitidine

Balraj Singh, Anthony Lucci|Oncotarget|2021

Cited by 18

Evaluation of 6-mercaptopurine in a cell culture model of adaptable triple-negative breast cancer with metastatic potential

Balraj Singh, Anthony Lucci|Oncotarget|2019

Cited by 12

Sensitization of Resistant Cells with a BET Bromodomain Inhibitor in a Cell Culture Model of Deep Intrinsic Resistance in Breast Cancer

Balraj Singh, Anthony Lucci|Cancers|2023

Cited by 6

Indexing the rest of 565 publications…